Химиотерапия колоректального рака: лучшие режимы
Ганьшина Инна Петровна, Ю. А. Барсуков · Вестник РОНЦ им. Н. Н. Блохина РАМН · 2006
This paper overviews the literature on a most important oncology problem, i.e. drug therapy of patients with colorectal cancer. The development of oxaliplatin, irinotecan, capecitabine, raltitrixed was a real breakthrough in colorectal cancer chemotherapy over the recent years. The clinical use of these drugs resulted in median survival in metastatic colorectal cancer reaching 24 months. Adjuvant chemotherapy in early colorectal cancer was also a considerable advance in cancer patient management. The overview describes the most efficient chemotherapy regimens including new anticancer agents.
Cited by 0 works.